Stocks scoring 25–45 beat the S&P 500
45.3% of the time over the next three months, since 2015.
How we measured this →
7
hedge funds
hold it · 1 new, 3 added, 2 trimmed
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s. ·
how the score works
Market cap
$6.9B
Industry
Medical Instruments & Supplies
Sector
Healthcare
Exchange
NYSE
About BAUSCH PLUS LOMB CORP
Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lenses that are indicated for therapeutic use and provide optical correction during healing. It also offers contact lens care products,…
Who's behind the signal
Every informed buyer we can see on BLCO, across all three feeds.
No significant Form 4 insider activity in the window.
Not a model pick — but on our radar.
BAUSCH PLUS LOMB CORP isn't in the top-10 model right now, but 7 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
7
Investors
1
New positions
3
Increasing
2
Decreasing
1
Unchanged
Price History
Loading price data...
Ctrl/⌘ + scroll or pinch to zoom · drag to measure · double-click to resetPinch to zoom · drag sideways to move through time
Return: High: Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
How much of each investor's portfolio is allocated to BAUSCH PLUS LOMB CORP
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell BAUSCH PLUS LOMB CORP or any security.